ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,683.00
-0.01%
S&P ASX All Technology
3,008.10
0.02%
Brent Oil
87.285
-0.32%
US Dollar vs AUD
1.5373
-0.24%
Bitcoin
66,663.36
0.38%
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Entrada Therapeutics Inc (TRDA)

  7. Entrada Therapeutics Inc (TRDA) News

TRDA Entrada Therapeutics Inc

12.89
0.00 (0.00%)
Pre Market
Last Updated: 20:09:16
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Entrada Therapeutics Inc TRDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 12.89 20:09:16
Open Price Low Price High Price Close Price Previous Close
12.89
more quote information »

Recent News

Date Time Source Heading
13/3/202422:00GLOBEEntrada Therapeutics Reports Fourth Quarter and Full Year..
09/3/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202408:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202408:22EDGAR2Form 144 - Report of proposed sale of securities
07/3/202408:22EDGAR2Form 144 - Report of proposed sale of securities
06/3/202411:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202411:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202411:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202423:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
03/1/202423:16EDGAR2Form 8-K - Current report
03/1/202423:00GLOBEEntrada Therapeutics Promotes Nathan J. Dowden to President
27/12/202308:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202308:26EDGAR2Form 144 - Report of proposed sale of securities
06/12/202323:00EDGAR2Form 8-K - Current report
23/11/202303:56DJNEntrada Therapeutics Shares Tumble 27% After FDA Keeps..
22/11/202323:54DJNEntrada: FDA Declines to Lift Hold on Duchenne Study
22/11/202323:35EDGAR2Form 8-K - Current report
22/11/202323:00GLOBEEntrada Therapeutics Announces Updates on ENTR-601-44 in..
07/11/202323:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202323:08EDGAR2Form 8-K - Current report
07/11/202323:00GLOBEEntrada Therapeutics Reports Third Quarter 2023 Financial..
01/11/202322:01EDGAR2Form 8-K - Current report
12/10/202322:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
30/9/202306:39EDGAR2Form 8-K - Current report
30/9/202306:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/9/202321:09EDGAR2Form 8-K - Current report
21/9/202321:00GLOBEEntrada Therapeutics Announces First Participant Dosed in..
07/9/202321:00GLOBEEntrada Therapeutics Awards Funding to Non-Profit..
07/9/202307:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202307:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202307:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202306:09EDGAR2Form 144 - Report of proposed sale of securities
07/9/202306:09EDGAR2Form 144 - Report of proposed sale of securities
07/9/202306:08EDGAR2Form 144 - Report of proposed sale of securities
06/9/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202306:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/8/202321:00GLOBEEntrada Therapeutics to Present at Upcoming Investor..
10/8/202321:09EDGAR2Form 8-K - Current report
10/8/202321:00GLOBEEntrada Therapeutics Appoints Gina Chapman to its Board of..
08/8/202321:25EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
08/8/202321:23EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
08/8/202321:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202321:07EDGAR2Form 8-K - Current report
08/8/202321:00GLOBEEntrada Therapeutics Reports Second Quarter 2023 Financial..
05/8/202306:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/8/202306:10EDGAR2Form 144 - Report of proposed sale of securities
01/8/202321:08EDGAR2Form 8-K - Current report
01/8/202321:00GLOBEEntrada Therapeutics Receives Authorization in the United..
13/7/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

NASDAQ
TRDA
Entrada Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved